Skip to content

Comparative study for routine indwelling catheterization of total hip arthroplasty under general anesthesia

Comparative study for routine indwelling catheterization of total hip arthroplasty under general anesthesia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900025648
Enrollment
Unknown
Registered
2019-09-03
Start date
2019-09-03
Completion date
Unknown
Last updated
2019-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hip-joint disease

Interventions

1:retention catheterization
2:No indwelling catheterization

Sponsors

Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients undergoing total hip arthroplasty; 2. Patients undergoing general anesthesia; 3. Aged 18-80 years.

Exclusion criteria

Exclusion criteria: 1. Double hip arthroplasty was performed simultaneously; 2. High risk factors for urinary retention: history of prostatic hyperplasia, moderate symptoms of Intemational Prostatesymptom Score (IPsS) and above (IPsS Score >= 8), previous history of postoperative urinary retention, dysuria in bed before surgery, and residual urine > 100ml after urination;Complex hip and knee arthroplasty with expected time > 3h; 3. Before the presence of urinary tract infection, urinary tract irritation signs, urethral stricture; 4. Patients with severe liver and kidney dysfunction need to have urinary catheter retained before operation.

Design outcomes

Primary

MeasureTime frame
postoperative VAS score;Postoperative hospitalization time;Postoperative urinary retention;surgery time;heter-related bladder discomfort;Incidence of urinary tract infection;

Countries

China

Contacts

Public ContactFeng Shuo

Affiliated Hospital of Xuzhou Medical University

781733181@qq.com+86 18552880088

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026